Literature DB >> 10412981

Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D.

C Jamora1, N Yamanouye, J Van Lint, J Laudenslager, J R Vandenheede, D J Faulkner, V Malhotra.   

Abstract

We have shown previously that the betagamma subunits of the heterotrimeric G proteins regulate the organization of the pericentriolarly localized Golgi stacks. In this report, evidence is presented that the downstream target of Gbetagamma is protein kinase D (PKD), an isoform of protein kinase C. PKD, unlike other members of this class of serine/threonine kinases, contains a pleckstrin homology (PH) domain. Our results demonstrate that Gbetagamma directly activates PKD by interacting with its PH domain. Inhibition of PKD activity through the use of pharmacological agents, synthetic peptide substrates, and, more specifically, the PH domain of PKD prevents Gbetagamma-mediated Golgi breakdown. Our findings suggest a possible mechanism by which the direct interaction of Gbetagamma with PKD regulates the dynamics of Golgi membranes and protein secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10412981     DOI: 10.1016/S0092-8674(00)80606-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  109 in total

1.  Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis.

Authors:  M Mancini; C E Machamer; S Roy; D W Nicholson; N A Thornberry; L A Casciola-Rosen; A Rosen
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

2.  Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement.

Authors:  X A Zhang; A L Bontrager; C S Stipp; S K Kraeft; G Bazzoni; L B Chen; M E Hemler
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

3.  Potential role for protein kinases in regulation of bidirectional endoplasmic reticulum-to-Golgi transport revealed by protein kinase inhibitor H89.

Authors:  T H Lee; A D Linstedt
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

Review 4.  Myelin biogenesis: vesicle transport in oligodendrocytes.

Authors:  J N Larocca; A G Rodriguez-Gabin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

5.  Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells.

Authors:  Yan Feng; Ashutosh P Jadhav; Chiara Rodighiero; Yukako Fujinaga; Tomas Kirchhausen; Wayne I Lencer
Journal:  EMBO Rep       Date:  2004-05-21       Impact factor: 8.807

6.  Regulation of constitutive cargo transport from the trans-Golgi network to plasma membrane by Golgi-localized G protein betagamma subunits.

Authors:  Roshanak Irannejad; Philip B Wedegaertner
Journal:  J Biol Chem       Date:  2010-08-18       Impact factor: 5.157

7.  Regulation of Golgi structure and secretion by receptor-induced G protein βγ complex translocation.

Authors:  Deepak Kumar Saini; W K Ajith Karunarathne; Nataraju Angaswamy; Deepti Saini; Joon-Ho Cho; Vani Kalyanaraman; Narasimhan Gautam
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 8.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

9.  The cytoplasmic accumulations of the cataract-associated mutant, Connexin50P88S, are long-lived and form in the endoplasmic reticulum.

Authors:  Alexandra Lichtenstein; Guido M Gaietta; Thomas J Deerinck; John Crum; Gina E Sosinsky; Eric C Beyer; Viviana M Berthoud
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

Review 10.  Protein kinase D: a new player among the signaling proteins that regulate functions in the nervous system.

Authors:  Gang Li; Yun Wang
Journal:  Neurosci Bull       Date:  2014-02-13       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.